New drug injected directly into brain shows promise in early trial for deadly cancer
Disease control
Completed
This early-phase study tested a new drug, I-123 ATT001, given directly into the brain cavity of 7 adults with relapsed glioblastoma, a severe brain cancer. The main goal was to check safety and find the right dose. The study is now complete, and results will help guide future res…
Phase: PHASE1 • Sponsor: Theragnostics Ltd • Aim: Disease control
Last updated May 13, 2026 15:59 UTC